351 related articles for article (PubMed ID: 11106548)
1. p63 is a prostate basal cell marker and is required for prostate development.
Signoretti S; Waltregny D; Dilks J; Isaac B; Lin D; Garraway L; Yang A; Montironi R; McKeon F; Loda M
Am J Pathol; 2000 Dec; 157(6):1769-75. PubMed ID: 11106548
[TBL] [Abstract][Full Text] [Related]
2. Differential expression of p63 isoforms in normal tissues and neoplastic cells.
Nylander K; Vojtesek B; Nenutil R; Lindgren B; Roos G; Zhanxiang W; Sjöström B; Dahlqvist A; Coates PJ
J Pathol; 2002 Dec; 198(4):417-27. PubMed ID: 12434410
[TBL] [Abstract][Full Text] [Related]
3. p63 protein expression is rare in prostate adenocarcinoma: implications for cancer diagnosis and carcinogenesis.
Parsons JK; Gage WR; Nelson WG; De Marzo AM
Urology; 2001 Oct; 58(4):619-24. PubMed ID: 11597556
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells.
Weinstein MH; Signoretti S; Loda M
Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011
[TBL] [Abstract][Full Text] [Related]
5. p63, a p53 homologue, is a selective nuclear marker of myoepithelial cells of the human breast.
Barbareschi M; Pecciarini L; Cangi MG; Macrì E; Rizzo A; Viale G; Doglioni C
Am J Surg Pathol; 2001 Aug; 25(8):1054-60. PubMed ID: 11474290
[TBL] [Abstract][Full Text] [Related]
6. p63 expression profile in normal and malignant prostate epithelial cells.
Davis LD; Zhang W; Merseburger A; Young D; Xu L; Rhim JS; Moul JW; Srivastava S; Sesterhenn IA
Anticancer Res; 2002; 22(6C):3819-25. PubMed ID: 12553000
[TBL] [Abstract][Full Text] [Related]
7. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells.
Zhou M; Shah R; Shen R; Rubin MA
Am J Surg Pathol; 2003 Mar; 27(3):365-71. PubMed ID: 12604893
[TBL] [Abstract][Full Text] [Related]
8. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study.
Stewart J; Fleshner N; Cole H; Sweet J
J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997
[TBL] [Abstract][Full Text] [Related]
9. The role of p63 and deltaNp63 (p40) protein expression and gene amplification in esophageal carcinogenesis.
Geddert H; Kiel S; Heep HJ; Gabbert HE; Sarbia M
Hum Pathol; 2003 Sep; 34(9):850-6. PubMed ID: 14562279
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
[TBL] [Abstract][Full Text] [Related]
11. Loss of p63 expression is associated with tumor progression in bladder cancer.
Urist MJ; Di Como CJ; Lu ML; Charytonowicz E; Verbel D; Crum CP; Ince TA; McKeon FD; Cordon-Cardo C
Am J Pathol; 2002 Oct; 161(4):1199-206. PubMed ID: 12368193
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of p63 protein in human esophageal squamous cell carcinomas.
Hu H; Xia SH; Li AD; Xu X; Cai Y; Han YL; Wei F; Chen BS; Huang XP; Han YS; Zhang JW; Zhang X; Wu M; Wang MR
Int J Cancer; 2002 Dec; 102(6):580-3. PubMed ID: 12447998
[TBL] [Abstract][Full Text] [Related]
13. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities.
Yang A; Kaghad M; Wang Y; Gillett E; Fleming MD; Dötsch V; Andrews NC; Caput D; McKeon F
Mol Cell; 1998 Sep; 2(3):305-16. PubMed ID: 9774969
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions.
Nylander K; Coates PJ; Hall PA
Int J Cancer; 2000 Aug; 87(3):368-72. PubMed ID: 10897041
[TBL] [Abstract][Full Text] [Related]
15. ΔNp63 (p40) expression in prostatic adenocarcinoma with diffuse p63 positivity.
Uchida K; Ross H; Lotan T; Pignon JC; Signoretti S; Epstein JI; Illei PB
Hum Pathol; 2015 Mar; 46(3):384-9. PubMed ID: 25548110
[TBL] [Abstract][Full Text] [Related]
16. Frequent alteration of p63 expression in human primary bladder carcinomas.
Park BJ; Lee SJ; Kim JI; Lee SJ; Lee CH; Chang SG; Park JH; Chi SG
Cancer Res; 2000 Jul; 60(13):3370-4. PubMed ID: 10910040
[TBL] [Abstract][Full Text] [Related]
17. Unique domain functions of p63 isotypes that differentially regulate distinct aspects of epidermal homeostasis.
King KE; Ponnamperuma RM; Gerdes MJ; Tokino T; Yamashita T; Baker CC; Weinberg WC
Carcinogenesis; 2006 Jan; 27(1):53-63. PubMed ID: 16081516
[TBL] [Abstract][Full Text] [Related]
18. p63 expression profiles in human normal and tumor tissues.
Di Como CJ; Urist MJ; Babayan I; Drobnjak M; Hedvat CV; Teruya-Feldstein J; Pohar K; Hoos A; Cordon-Cardo C
Clin Cancer Res; 2002 Feb; 8(2):494-501. PubMed ID: 11839669
[TBL] [Abstract][Full Text] [Related]
19. DNA-binding and transactivation activities are essential for TAp63 protein degradation.
Ying H; Chang DL; Zheng H; McKeon F; Xiao ZX
Mol Cell Biol; 2005 Jul; 25(14):6154-64. PubMed ID: 15988026
[TBL] [Abstract][Full Text] [Related]
20. p63 regulates commitment to the prostate cell lineage.
Signoretti S; Pires MM; Lindauer M; Horner JW; Grisanzio C; Dhar S; Majumder P; McKeon F; Kantoff PW; Sellers WR; Loda M
Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11355-60. PubMed ID: 16051706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]